Mizuho Sticks With Outperform on EyePoint as Shares Lag Peers
Mizuho has reaffirmed an Outperform rating and a $33.00 price target for EyePoint, Inc. (NASDAQ:EYPT) despite the stock's notable year-to-date decline. The firm emphasized that the share weakness has not been driven by changes in company fundamentals and highlighted upcoming clinical readouts across the sector - including a competitor's Phase 3 Axp…